Home » Transcept to Try Again With Sleep Disorder Drug
Transcept to Try Again With Sleep Disorder Drug
Transcept Pharmaceuticals Inc plans to resubmit a new drug application with U.S. regulators for its sleep-disorder drug Intermezzo after a study showed no significant effect on driving after four hours.
Finanz Nachrichten
Finanz Nachrichten
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May